[ET Net News Agency, 27 August 2021] HANSOH PHARMA (03692) fell 11.17% to HK$19.72.
It hits an intra-day low of HK$19.72, hitting a 52-week low, and an intra-day high of
HK$21.7. The total shares traded was 3.67 million, with a value of HK$75.56m. The active
buy/sell ratio is 49:51, with net selling turnover of HK$951,060. J.P. MORGAN BRO (HK)
accounts for greatest net responsive buying turnover of HK$4.5m, with volume weighted
average price of HK$20.608. CREDIT SUISSE (HK) SEC accounts for greatest net responsive
selling turnover of HK$5.37m, with volume weighted average price of HK$20.702. The stock
has fallen a combined 12.94% over the past 3 consecutive trading days.
The Hang Seng Index now rose 144 points, or 0.57% to 25,559; the Hang Seng China
Enterprises Index now rose 95 points, or 1.07% to 9,033; the Hang Seng TECH Index now rose
87 points, or 1.38% to 6,424; with an overall turnover of HK$54.36b.
The SSE Composite Index now rose 18 points, or 0.53% to 3,520, with an overall turnover
of RMB322.34b.
The SZSE Component Index now rose 52 points, or 0.37% to 14,468, with an overall
turnover of RMB182.42b.
Basic Information
-------------------------------------------
Nominal 19.720 % Chg -11.17%
High 21.700 Low 19.720
Shares Tr 3.67m Turnover 75.56m
10-D SMA 23.582 %H.V 47.838
20-D SMA 25.579 VWAP 20.588
50-D SMA 29.143 RSI14 21.120
-------------------------------------------
Status: Hitting a 52-week low, active buy/sell ratio is 49:51, with net selling turnover
of HK$951,060, falling a combined 12.94% over the past 3 consecutive trading
days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
HANSOH PHARMA (03692) 19.72 -11.17
SIHUAN PHARM (00460) 2.17 -1.81
CMS (00867) 14.88 -4.74
CSPC PHARMA (01093) 9.98 -0.60
SINO BIOPHARM (01177) 6.29 +0.48
3SBIO (01530) 8.09 +8.74
SIMCERE PHARMA (02096) 7.78 +1.57
FOSUN PHARMA (02196) 52.05 +1.26
WUXI APPTEC (02359) 146.50 +2.38
PHARMARON (03759) 163.10 +2.00
-------------------------------------------------
(ed)